Yujie Cui

540 total citations
23 papers, 368 citations indexed

About

Yujie Cui is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yujie Cui has authored 23 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Yujie Cui's work include Caveolin-1 and cellular processes (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and HER2/EGFR in Cancer Research (3 papers). Yujie Cui is often cited by papers focused on Caveolin-1 and cellular processes (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and HER2/EGFR in Cancer Research (3 papers). Yujie Cui collaborates with scholars based in China, United States and Macao. Yujie Cui's co-authors include Jiaqi Xu, Heng Gao, Aiming Pang, Tienian Zhu, Ruijing Zhao, Ni Cheng, Xiaoping Du, Minyi Gu, Michael Keegan Delaney and Xiaoyu Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The FASEB Journal.

In The Last Decade

Yujie Cui

23 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujie Cui China 12 191 64 62 54 50 23 368
Sandra Canosa United States 10 230 1.2× 51 0.8× 85 1.4× 54 1.0× 47 0.9× 13 476
Klarke M. Sample China 9 145 0.8× 43 0.7× 43 0.7× 50 0.9× 22 0.4× 22 278
Jun‐ichi Suehiro Japan 13 346 1.8× 88 1.4× 80 1.3× 101 1.9× 48 1.0× 22 526
Ehsan Ghayoor Karimiani Iran 12 180 0.9× 33 0.5× 123 2.0× 47 0.9× 38 0.8× 46 476
Wa Du United States 9 277 1.5× 51 0.8× 48 0.8× 44 0.8× 24 0.5× 15 396
Paul Coleman Australia 16 229 1.2× 60 0.9× 87 1.4× 46 0.9× 34 0.7× 20 494
Jessica Cassavaugh United States 9 254 1.3× 150 2.3× 32 0.5× 66 1.2× 86 1.7× 13 467
Junko Zenkoh Japan 9 134 0.7× 43 0.7× 60 1.0× 70 1.3× 43 0.9× 18 333
Benjamin N. Ostendorf Germany 11 221 1.2× 117 1.8× 121 2.0× 115 2.1× 64 1.3× 19 493
Amy C. Ladd United States 12 306 1.6× 100 1.6× 50 0.8× 49 0.9× 42 0.8× 22 507

Countries citing papers authored by Yujie Cui

Since Specialization
Citations

This map shows the geographic impact of Yujie Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujie Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujie Cui more than expected).

Fields of papers citing papers by Yujie Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujie Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujie Cui. The network helps show where Yujie Cui may publish in the future.

Co-authorship network of co-authors of Yujie Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yujie Cui. A scholar is included among the top collaborators of Yujie Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujie Cui. Yujie Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Yujie, Paul Marano, Janet Wei, et al.. (2025). Psychosocial and clinical characteristics in Takotsubo syndrome. Biology of Sex Differences. 16(1). 42–42. 1 indexed citations
2.
Cui, Yujie, Janet Wei, Martha Gulati, et al.. (2024). Elevated high-density lipoprotein cholesterol and adverse outcomes in women with symptoms of ischemic heart disease. SHILAP Revista de lepidopterología. 40. 100376–100376. 2 indexed citations
3.
Chung, Alice, Catherine Dang, Scott Karlan, et al.. (2024). A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer. Annals of Surgical Oncology. 31(5). 3160–3167. 5 indexed citations
4.
Egelston, Colt A., Weihua Guo, Susan E. Yost, et al.. (2023). Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer Immunology Immunotherapy. 72(9). 3013–3027. 14 indexed citations
5.
Yuan, Yuan, Susan E. Yost, Yujie Cui, et al.. (2023). Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer. The Oncologist. 28(7). e498–e507. 9 indexed citations
6.
Wei, Janet, et al.. (2023). Association of Coronary Artery Dominance With Long-term Outcomes in Female Patients With Suspected Ischemia but Nonobstructive Coronary Artery Disease. Journal of the Society for Cardiovascular Angiography & Interventions. 2(5). 101064–101064. 1 indexed citations
7.
Liu, Jia, Tienian Zhu, Jiankun Liu, et al.. (2023). Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer. Acta Biochimica et Biophysica Sinica. 55(8). 1247–1256. 4 indexed citations
8.
Liu, Miao, Wei Dong, Qian Nie, et al.. (2022). Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes. Taiwanese Journal of Obstetrics and Gynecology. 61(4). 663–671. 8 indexed citations
9.
Liu, Defeng, Dan Du, Tao Zheng, et al.. (2022). Multi-Parameter MR Radiomics Based Model to Predict 5-Year Progression-Free Survival in Endometrial Cancer. Frontiers in Oncology. 12. 813069–813069. 13 indexed citations
10.
Cui, Yujie, Jia Liu, Miao Liu, & Hongzhen Zhang. (2021). Observation on the Clinical Effect of Apatinib Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer. Pakistan Journal of Medical Sciences. 37(4). 1036–1041. 3 indexed citations
11.
Pang, Aiming, Ni Cheng, Yujie Cui, et al.. (2020). High-loading Gα 13 -binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injury. Science Translational Medicine. 12(552). 32 indexed citations
12.
Cui, Yujie, et al.. (2019). miR-140-5p Attenuates Neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4. Inflammation. 42(5). 1869–1877. 35 indexed citations
13.
Pang, Aiming, Ya‐Hui Hu, Pengfei Zhou, et al.. (2019). Corin plays a protective role via upregulating MAPK and downregulating eNOS in diabetic nephropathy endothelial dysfunction. The FASEB Journal. 34(1). 95–106. 11 indexed citations
14.
Pang, Aiming, Yujie Cui, Yunfeng Chen, et al.. (2018). Shear-induced integrin signaling in platelet phosphatidylserine exposure, microvesicle release, and coagulation. Blood. 132(5). 533–543. 56 indexed citations
16.
Guo, Yanli, Tienian Zhu, Wei Guo, et al.. (2016). Aberrant CpG Island Shore Region Methylation of CAV1 Is Associated with Tumor Progression and Poor Prognosis in Gastric Cardia Adenocarcinoma. Archives of Medical Research. 47(6). 460–470. 10 indexed citations
17.
Zhu, Tienian, Yujie Cui, Gang Zhang, et al.. (2015). Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion. Medical Oncology. 32(7). 207–207. 16 indexed citations
18.
Cui, Yujie, Xiaoyu Liu, Tingting Yang, Yan‐Ai Mei, & Changlong Hu. (2013). Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway. Cell Calcium. 55(1). 48–58. 35 indexed citations
19.
Dong, Ningzheng, Yujie Cui, & Changgeng Ruan. (2009). [Generation of human Fab antibody against platelet membrane glycoprotein IIb/IIIa and its effect on platelet aggregation].. PubMed. 25(1). 65–7. 1 indexed citations
20.
Tang, Huadong, Yan Fu, Yujie Cui, et al.. (2008). Fibrinogen has chaperone-like activity. Biochemical and Biophysical Research Communications. 378(3). 662–667. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026